Optimization, ex-vivo penetration and in-vivo evaluation of PEGylated nanostructured lipid carriers of olmesartan medoxomil to enhance transdermal delivery
Advanced Pharmaceutical Bulletin · 19.05.2026
DOI: 10.34172/apb.46458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 19.05.2026. Verfasst von Rofida Albash und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza, Egypt. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Olmesartan medoxomil (OLM), a scarce water soluble hypertension medication with 26% oral bioavailability, was to be encapsulated in PEGylated nanostructured lipid carriers (PNLCs) for transdermal distribution. Tween 80 or sodium deoxycholate stabilized the PNLCs, which were made up of liquid lipid including a mixture of medium chain triglycerides (labrasol and labrafil) and solid lipid (compritol and tristearin). Hot melt emulsification, high-speed stirring, and ultrasonication were used to create PNLCs. To distinguish the effects of formulation independent variables on entrapment efficiency %, particle size, polydispersity index, zeta potential, and amount of drug released after 6 hours (Q6h), a 24 complete factorial design using Design Expert® software was created.For additional research, the formula (PNLC16) with the best requirements was chosen. When compared to OLM solution, PNLC16 permeation was more potent when done ex vivo using both shed snake and rat skin. Histopathological analysis demonstrated that the topically administered PNLCs were safe. Pharmacodynamic research further demonstrated PNLC16's superiority over commercial oral pills in terms of long-lasting effects. All things considered, the results showed that PNLC16 would be a viable vehicle for OLM transdermal delivery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza, Egypt.
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, University of Hertfordshire, New Capital, Egypt.
ORCID-Profile: Rofida Albash
Zitieren
APA
Albash, R., Abdelbary, A. A., Refai, H., & El-Nabarawi, M. A. (2026). Optimization, ex-vivo penetration and in-vivo evaluation of PEGylated nanostructured lipid carriers of olmesartan medoxomil to enhance transdermal delivery. Advanced Pharmaceutical Bulletin. https://doi.org/10.34172/apb.46458
Vancouver
Albash R, Abdelbary AA, Refai H, El-Nabarawi MA. Optimization, ex-vivo penetration and in-vivo evaluation of PEGylated nanostructured lipid carriers of olmesartan medoxomil to enhance transdermal delivery. Advanced Pharmaceutical Bulletin. 2026. doi:10.34172/apb.46458
BibTeX
@article{Albash2026,
author = {Albash, Rofida and Abdelbary, Aly A and Refai, Hanan and El-Nabarawi, Mohamed A},
title = {Optimization, ex-vivo penetration and in-vivo evaluation of PEGylated nanostructured lipid carriers of olmesartan medoxomil to enhance transdermal delivery},
journal = {Advanced Pharmaceutical Bulletin},
year = {2026},
doi = {10.34172/apb.46458}
}
EUVIMED